All FDA articles – Page 5
-
Business
Drug firms warned to be honest with investors
Official warns of ‘significant consequences’ if companies aren’t forthcoming about their FDA interactions
-
Business
US approves biosimilar filgrastim
Sandoz’s version of Amgen’s Neupogen is ‘biosimilar’ but not ‘interchangeable’
-
NewsCaramel colour in soft drinks linked to cancer
Regulatory bodies and researchers sceptical of study on 4-MEI found in food colour
-
BusinessUS opens up home DNA screening
FDA approves single disease genetic test and clears pathway for similar devices
-
Business
Teva wins generic esomeprazole race
US approval of heartburn drug after Ranbaxy version was withdrawn by regulators
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
BusinessUS poised to approve its first ‘biosimilar’ drug
FDA panel recommends Sandoz’s copy of Amgen’s Neupogen
-
-
Business
Ranbaxy sues over withdrawn US approvals
Company says decision is ‘unconstitutional’ and deprives it of hundreds of millions of dollars in revenue
-
Business
Single shot antibiotic approved for skin infections
Third drug in three months approved under US antimicrobials incentive scheme
-
Business
Drug giants settle mismarketing lawsuits
Pfizer and GSK settle claims over promoting drugs for unapproved uses in the US
-
Business
Generics giants jostle over pain drug
Mylan and Actavis contest Teva’s generic celecoxib exclusivity
-
Business
Boehringer to settle blood thinner drug suits for $650m
Company confident in drug safety but says court cases are too risky
-
Business
Contamination troubles strike GSK
GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
-
Business
US focuses pharma supply chain scrutiny
Import pre-authorisation for trusted firms frees up resources to tackle purity problems
-
NewsPoliticians accuse US food agency of illegally monitoring employees
Republican staff report calls the Food and Drug Administration’s surveillance of whistleblowers unlawful
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
-
NewsFDA wants the dirt on antibacterial soaps
US manufacturers will have to prove their products are safe and more effective than ordinary soap, under a proposed rule